In addition, PNVs and EA mitigated hepatic fibrosis, as indicated by Sirius red staining and the reduced levels of TGF, α‐SMA, and MMP2 in WD‐mediated MASLD. The gene discussed is MMP2; the disease is metabolic dysfunction-associated steatotic liver disease.